Royal Bank of Canada’s Cocrystal Pharma COCP Stock Holding History

Royal Bank of Canada’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Sell	9 -42	-82%	-$52	﹤0.01%	7425
2026 Q1	$0	Hold	51	–	–	﹤0.01%	7196
2025 Q4	$0	Hold	51	–	–	﹤0.01%	7225
2025 Q3	$0	Hold	51	–	–	﹤0.01%	7178
2025 Q2	$0	Hold	51	–	–	﹤0.01%	7065
2025 Q1	$0	Hold	51	–	–	﹤0.01%	6867
2024 Q4	$0	Hold	51	–	–	﹤0.01%	6931
2024 Q3	$0	Hold	51	–	–	﹤0.01%	6926
2024 Q2	$0	Hold	51	–	–	﹤0.01%	7109
2024 Q1	$0	Buy	51 +42	+467%	+$65	﹤0.01%	7075
2023 Q4	$0	Hold	9	–	–	﹤0.01%	7173
2023 Q3	$0	Hold	9	–	–	﹤0.01%	7140
2023 Q2	$0	Hold	9	–	–	﹤0.01%	7306
2023 Q1	$0	Hold	9	–	–	﹤0.01%	7120
2022 Q4	$0	Buy	9 +1	+13%	+$3	﹤0.01%	7284
2022 Q3	$0	Hold	8	–	–	﹤0.01%	7491
2022 Q2	$0	Buy	+8	New	+$43	﹤0.01%	7406
2020 Q3	–	Sell	-93	Closed	-$2K	–	6659
2020 Q2	$2K	Sell	93 -14,771	-99%	-$181K	﹤0.01%	6272
2020 Q1	$126K	Buy	14,864 +14,853	+135,027%	+$140K	﹤0.01%	4626
2019 Q4	$0	Sell	11 -59,453	-100%	-$594K	﹤0.01%	6851
2019 Q3	$1.46M	Buy	59,464 +27	+0%	+$700	﹤0.01%	3013
2019 Q2	$1.68M	Hold	59,437	–	–	﹤0.01%	2897
2019 Q1	$1.95M	Buy	59,437 +59,270	+35,491%	+$2.17M	﹤0.01%	2706
2018 Q4	$7K	Hold	167	–	–	﹤0.01%	6025
2018 Q3	$5K	Hold	167	–	–	﹤0.01%	6249
2018 Q2	$7K	Sell	167 -166	-50%	-$6.16K	﹤0.01%	5924
2018 Q1	$24K	Buy	+333	New	+$20.8K	﹤0.01%	5384

Other funds holding COCP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Royal Bank of Canada's COCP Position: Q2 2026 in Review

Royal Bank of Canada reduced its Cocrystal Pharma (COCP) stake by 82% in Q2 2026, selling an estimated $52 and leaving 9 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7425.

Royal Bank of Canada first reported a position in COCP in Q1 2018 and has held it in 27 quarters since. The position peaked at $1.95M in Q1 2019. 27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

Royal Bank of Canada held 9 shares of Cocrystal Pharma worth $0 as of Q2 2026.
Royal Bank of Canada sold 42 Cocrystal Pharma shares in Q2 2026, an estimated $52.
Cocrystal Pharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7425 holding.
Royal Bank of Canada first reported a position in Cocrystal Pharma in Q1 2018 and has held it in 27 quarters since.
Royal Bank of Canada's Cocrystal Pharma position peaked at $1.95M in Q1 2019.
27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.